First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn; Aaron S. Mansfield; Aleksandra Szczęsna; Libor Havel; Maciej Krzakowski; Maximilian J. Hochmair; Florian Huemer; György Losonczy; Melissa L. Johnson; Makoto Nishio; Martin Reck; Tony Mok; Bernd Lamprecht; et al.

doi:10.1056/NEJMoa1809064

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn
, Aaron S. Mansfield
, Aleksandra Szczęsna
, Libor Havel
, Maciej Krzakowski
, Maximilian J. Hochmair
, Florian Huemer
, György Losonczy
, Melissa L. Johnson
, Makoto Nishio
, Martin Reck
, Tony Mok
, Bernd Lamprecht
, et al.

Department of Internal Medicine 4 - Pneumology and Infectious Diseases

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2220-2229
Number of pages	10
Journal	The New England Journal of Medicine
Volume	379
Issue number	23
DOIs	https://doi.org/10.1056/NEJMoa1809064
Publication status	Published - 06 Dec 2018

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

JKU Focus areas

Medical Sciences (in general)
Health System Research
Clinical Research on Aging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMoa1809064

Cite this

Horn, L., Mansfield, A. S., Szczęsna, A., Havel, L., Krzakowski, M., Hochmair, M. J., Huemer, F., Losonczy, G., Johnson, M. L., Nishio, M., Reck, M., Mok, T., Lamprecht, B., & et al. (2018). First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. The New England Journal of Medicine, 379(23), 2220-2229. https://doi.org/10.1056/NEJMoa1809064

@article{937dc229062542e7a3a0bbf22c29942b,

title = "First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer",

author = "Leora Horn and Mansfield, \{Aaron S.\} and Aleksandra Szcz{\c e}sna and Libor Havel and Maciej Krzakowski and Hochmair, \{Maximilian J.\} and Florian Huemer and Gy{\"o}rgy Losonczy and Johnson, \{Melissa L.\} and Makoto Nishio and Martin Reck and Tony Mok and Bernd Lamprecht and \{et al.\}",

year = "2018",

month = dec,

day = "6",

doi = "10.1056/NEJMoa1809064",

language = "English",

volume = "379",

pages = "2220--2229",

journal = "The New England Journal of Medicine",

issn = "1533-4406",

number = "23",

}

TY - JOUR

T1 - First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

AU - Horn, Leora

AU - Mansfield, Aaron S.

AU - Szczęsna, Aleksandra

AU - Havel, Libor

AU - Krzakowski, Maciej

AU - Hochmair, Maximilian J.

AU - Huemer, Florian

AU - Losonczy, György

AU - Johnson, Melissa L.

AU - Nishio, Makoto

AU - Reck, Martin

AU - Mok, Tony

AU - Lamprecht, Bernd

AU - et al., null

PY - 2018/12/6

Y1 - 2018/12/6

UR - https://www.ncbi.nlm.nih.gov/pubmed/30280641

UR - https://www.scopus.com/pages/publications/85054383617

U2 - 10.1056/NEJMoa1809064

DO - 10.1056/NEJMoa1809064

M3 - Article

SN - 1533-4406

VL - 379

SP - 2220

EP - 2229

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 23

ER -

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Fields of science

JKU Focus areas

UN SDGs

Access to Document

Other files and links

Cite this